Grail (GRAL) Shares Outstanding (2023 - 2026)
Grail's (GRAL) quarterly Shares Outstanding (Entity) came in at $44.7 million in Q2 2026, up 23.91% on a YoY basis from $36.0 million in Q2 2025, and up 8.59% quarter-over-quarter from $41.1 million in Q1 2026.
Analysis
Grail (GRAL) Shares Outstanding (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Shares Outstanding (Entity) for 4 consecutive years, with $44.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 23.91% year-over-year to $44.7 million; the trailing twelve-month figure through Jun 2026 stood at $44.7 million (up 23.91% YoY), and the FY2025 full-year result was $40.3 million, up 18.99% from the prior year.
- Shares Outstanding (Entity) grew to $44.7 million in Q2 2026 per GRAL's latest filing, from $41.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $44.7 million in Q2 2026 and bottomed at $31.0 million in Q2 2023.
- Historically, Shares Outstanding (Entity) has averaged $35.1 million across 4 years, with a median of $33.9 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) changed 0.0% in 2024, then climbed 23.91% in 2026.
- Over 4 years, Shares Outstanding (Entity) stood at $31.0 million in 2023, then climbed by 9.16% to $33.9 million in 2024, then gained by 18.99% to $40.3 million in 2025, then rose by 10.75% to $44.7 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $44.7 million, $41.1 million, and $40.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 143.28 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 111.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 81.70 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 132.87 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 179.92 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 282.89 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 285.77 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 46.40 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 159.86 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 43.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.11 Mn |
| Mar 31, 2026 | 40.64 Mn |
| Dec 31, 2025 | 36.75 Mn |
| Sep 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 35.79 Mn |
| Mar 31, 2025 | 34.31 Mn |
| Dec 31, 2024 | 31.90 Mn |
| Sep 30, 2024 | 31.88 Mn |
| Jun 30, 2024 | 31.05 Mn |
| Mar 31, 2024 | 31.05 Mn |
| Dec 31, 2023 | 31.05 Mn |
| Oct 1, 2023 | 31.05 Mn |
| Jun 30, 2023 | 31.05 Mn |